US authorises J&J's single-dose Covid-19 vaccine for emergency use

Shipments to vaccination sites are expected to begin on Sunday or Monday

US authorises J&J’s single-dose Covid-19 vaccine for emergency use
Reuters
2 min read Last Updated : Mar 01 2021 | 2:02 AM IST
The US government authorised Johnson & Johnson’s single-dose Covid-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.
 
The J&J vaccine is the third authorised in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses. Shipments to vaccination sites are expected to begin on Sunday or Monday.
 

US virus cases may stick at 70,000 a day, fears Fauci
 
The case baseline at 70,000 a day, needs to fall further before the US can confidently resume normal activities, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

 
China rolls out its single dose Covid-19 vaccine
 

China has given conditional approval for a single dose vaccine, touted to be a rival to Johnson & Johnson’s one-jab shot cleared by the US drug regulator on Sunday. Ad5-nCoV was rolled out on Friday.
 
New Zealand calls 7-day lockdown in largest city
 
New Zealand Prime Minister Jacinda Ardern announced a lockdown for its largest city Auckland while authorities investigate a new case of Covid. Auckland will enter the lockdown from 6 am on Sunday.
 
UAE cases drop 22% from late January peak
 
Covid cases in the United Arab Emirates have fallen by more than a fifth from a late January peak, a slower rate of decline than in Israel and the United Kingdom. Cases started rising again at the end-2020.
 


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineJohnson and Johnson

Next Story